Please login to the form below
Takecab
This page shows the latest Takecab news and features for those working in and with pharma, biotech and healthcare.
Biologics set to revolutionise the gastrointestinal market
Also contributing to the predicted market growth are recent product approvals such as Takeda's Takecab (vonoprazan) for gastroesophageal reflux disease, and Entvio (vedolizumab) for IBD.
Latest news
-
Rare disease therapies head the ‘class of 2015’
Baxalta. USA. vonoprazan fumarate. Takecab. acid-related diseases. potassium-competitive acid blocker. Takeda/Otsuka.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Moving annual total (MAT)
- Novartis highlights emerging assets and late-stage pipeline at R&D day
- Genital herpes vaccine candidate heads for human studies
- PMEA 2019 Winners Gallery - PMEA
- Creativity in storytelling: why pharma must invest more in creativity
- UPDATED: BMS completes Celgene merger after FTC okay
- Five key trends in precision and personalised healthcare
- Biogen defends aducanumab filing plan amid scepticism
- UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial
- Novartis strengthens case for its combination asthma drug
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Sage slides off a MOUNTAIN as depression drug flunks trial
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Five key trends in precision and personalised healthcare
- Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
- Language barriers: Obesity has become a loaded word
- ...
Quick links
Infographics
